Literature DB >> 3493893

[Significant association of HLA-B8 with systemic lupus erythematosus and with specific serological markers].

C Specker, H J Lakomek, B M Kuntz, G Bremer, G Goerz, H L Krüskemper.   

Abstract

Analysis of the HLA antigens of the A, B and C locus of 87 patients with systemic lupus erythematosus (SLE) revealed a significant elevation for HLA-B8 of 64% as compared to 22% in a healthy control group (n = 1850) (P less than 0.000001). Owing to the known linkage disequilibrium of this genetic marker with the HLA-A1 antigen, the HLA phenotype A1, B8 was found in 55% of the SLE patients (P less than 0.000001). Moreover, a significant association of the HLA-B8 in 82% (P less than 0.025) of Ro antibody-positive SLE patients (n = 22) and in 84% (P less than 0.025) of Ha antibody-positive patients (n = 19) was striking. A more frequent occurrence of this HLA antigen could also be detected in patients with a persistent nDNA antibody elevation and in patients with manifestation of the disease before the 40th year of life as compared to patients who manifested it later. An association of the HLA-B8 antigen with a raised disease activity of SLE can be inferred.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3493893     DOI: 10.1055/s-2008-1068100

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  2 in total

1.  The genetic basis of Ro and La antibody formation in systemic lupus erythematosus. Results of a multicenter study. The SLE Study Group.

Authors:  K Hartung; H Ehrfeld; H J Lakomek; R Coldewey; B Lang; F Krapf; R Müller; D Schendel; H Deicher; H P Seelig
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

2.  Differences in HLA antigens between patients with mixed connective tissue disease and systemic lupus erythematosus.

Authors:  P Ruuska; R Hämeenkorpi; S Forsberg; H Julkunen; R Mäkitalo; J Ilonen; A Tiilikainen
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.